Company Overview of PILA PHARMA AB
PILA PHARMA AB develops TRPV1 antagonist, an oral anti-diabetic agent to treat diabetes. The company was founded in 2014 and is based in Malmö, Sweden.
Medeon Science Park
Per Albin Hanssons väg 41
Malmö, 205 12
Founded in 2014
46 7 39 03 69 69
Key Executives for PILA PHARMA AB
PILA PHARMA AB Key Developments
Similar Private Companies By Industry
|Aditech Pharma AB||Europe|
|Apotek Produktion & Laboratorier AB||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact PILA PHARMA AB, please visit pilapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.